Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Gross Margin (2021 - 2026)

Core Scientific has reported Gross Margin over the past 6 years, most recently at 26.12% for Q1 2026.

  • Quarterly results put Gross Margin at 26.12% for Q1 2026, up 1580.0% from a year ago — trailing twelve months through Mar 2026 was 16.85% (up 429.0% YoY), and the annual figure for FY2025 was 11.88%, down 1183.0%.
  • Gross Margin reached 26.12% in Q1 2026 per CORZ's latest filing, roughly flat from 26.02% in the prior quarter.
  • Across five years, Gross Margin topped out at 43.31% in Q1 2024 and bottomed at 38.96% in Q4 2022.
  • Median Gross Margin over the past 5 years was 13.66% (2023), compared with a mean of 13.8%.
  • The largest annual shift saw Gross Margin tumbled -8581bps in 2022 before it skyrocketed 6665bps in 2023.
  • Over 5 years, Gross Margin stood at 38.96% in 2022, then surged by 171bps to 27.69% in 2023, then tumbled by -82bps to 5.02% in 2024, then surged by 419bps to 26.02% in 2025, then grew by 0bps to 26.12% in 2026.
  • Business Quant data shows Gross Margin for CORZ at 26.12% in Q1 2026, 26.02% in Q4 2025, and 4.81% in Q3 2025.